svx: unlocking the capital markets for healthcare companies - mars future of medicine™

24
Future of Medicine: Unlocking the Capital Markets for Healthcare Companies October 31, 2013 Contact: Carlos Pinto Lobo: [email protected]

Upload: mars-discovery-district

Post on 23-Jan-2015

646 views

Category:

Business


1 download

DESCRIPTION

Are you a health-science entrepreneur currently raising capital or planning to raise capital in the coming months? The SVX is a private investment platform built to connect impact ventures, funds and investors. Its aim is to catalyze new debt and equity investment capital for ventures that have demonstrable social or environmental impact and the potential for financial return. The SVX will present its platform and discuss the potential for healthcare companies to use the SVX to reach new sources of debt and equity capital.

TRANSCRIPT

Page 1: SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™

Future&of&Medicine:&Unlocking)the)Capital)Markets)for)Healthcare)Companies)October)31,)2013)

Contact:(Carlos)Pinto)Lobo:)[email protected])

Page 2: SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™

1"

Page 3: SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™

3"

Page 4: SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™

Pg."3"

  Ventures&lack&access&to&capital:&70%"of"impact"ventures"report"that"access"to"capital"is"a"major"challenge"to"their"success."

  Raising&capital&is&costly:&It"can"cost"tens"to"hundreds"of"thousands"of"dollars"for"impact"ventures"to"raise"capital.""

  Due&diligence&is&costly&and&9me&

consuming:&It"can"be"costly"and"?me"consuming"for"investors"to"conduct"due"diligence."

  There&is&an&uncoordinated&impact&

inves9ng&marketplace:&No"access"point"to"find"investment"opportuni?es"or"connect"with"investors."

Problem&There)is)growing)group)of)social)entrepreneurs)and)impact)investors,)but...)

Page 5: SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™

Pg."4"

  SVX&is"registered"as"a"restricted"dealer"with"the"Ontario"Securi?es"Commission."

  Access:&We"are"a"single"point"of"access"to"a"diverse"range"of"impact"investment"opportuni?es""

  Cost&effec9ve:&Our"services"are"available"at"very"low"or"no"cost;"thereby"reducing"transac?on"and"opera?on"costs."

  An&independent,&values&driven,&nonF

profit&organiza9on:&SVX"is"commiKed"to"suppor?ng"and"enabling"the"growth"of"impact"inves?ng"to"benefit"social,"environmental"and"economic"development."

Solu9on&The)first)plaHorm)of)its)kind)in)the)world)

Page 6: SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™

Impact Investing

Pg."5"

+"Solu9on&A)single)access)point)for)impact)ventures)and)investors)

Page 7: SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™

Target Issuers

Impact ventures and funds (<$25M revenues) including nonprofits (including charities), co-operatives (nonprofits and for-profits), and for-profit businesses looking for $25k - $10M.

Pg."6"

"

Who are the target ventures and funds?

Page 8: SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™

Target Issuers Who are the target ventures and funds?

Pg."7"

Page 9: SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™

Target&Investors&

  Accredited&investors&as"defined"under"the"Ontario"Securi?es"Commission"(OSC)"regula?ons"(or"the"equivalent"in"other"jurisdic?ons)."

  Investors"will"include"founda9ons&and&endowments&(private,&public,&or&

community),&asset&managers,&wealth&

advisors,&and&high&net&worth&

individuals"that"meet"the"defini?onal"requirements"of"an"accredited"investor"as"per"securi?es"regula?ons."

  Pa9ent,&impactFfirst&investors&with"a"focus"on"achieving"posi?ve"social"and/or"environmental"outcomes"and"modest"to"market"financial"returns"

Pg."8"

Who)are)the)target)investors)for)SVX?)

Page 10: SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™

Investor&Challenges&

  Lack&of&deal&flow:&Given"limited"resources,"impact"investors"cannot"easily"iden?fy"quality"impact"investments"in"order"to"make"an"appropriate"investment."

"  Lack&of&exper9se:&Impact"investors"do"not"

always"have"the"ability"to"prepare"and"conduct"due"diligence."

&

•  There&is&a&tremendous&opportunity&in&the&

growing&marketplace:&Currently"the"total"Canadian"impact"investment"market"is"$5.3"billion"and"is"expected"to"grow"to"$30"billion"in"10"years."""

Pg."9"

What)challenges)do)investors)face?)

Page 11: SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™

Pg."10"

Features&&&Benefits&How)does)SVX)work?)

Page 12: SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™

Governance&&&Management&"

•  Ontario"incorporated"•  Strong"governance"structure"•  Evidence"of"relevant"exper?se"within"

management"and/or"directors"•  Disclosure"of"any"current"or"past"legal"ac?ons"

against"management"and/or"directors"

Impact&"

•  Ontario[focused"impact"•  Five"(5)"Key"Performance"Indicators"(IRIS[

based"if"possible)"•  GIIRS,"3rd"party"ra?ng"(or"B"Corp),"for"social"

purpose"businesses"•  Impact"narra?ve"

Financials&"

•  Revenue[genera?ng"($50k"["$25M"annually)"•  Audited"or"reviewed"financial"statements"•  Pro[forma"projec?ons"•  Adequate"current"assets,"fixed"assets,"or"cash"

reserves"•  Ownership"informa?on,"including"past"and"

current"sources"of"capital""

Other&"

•  Complete"business"plan"•  External,"professional"references"•  Auditor/reviewer"&"legal"counsel"contact"

informa?on"•  Debt"&/or"equity"capital"need"($25k[10M"for"

ventures,"$2[50M+"for"funds)"•  IP"&"R&D"informa?on"(if"necessary"should"

venture"not"meet"revenue"requirements)"

Target&Issuers&

PLATFORM&ACCESS&REQUIREMENT&SUMMARY&

Pg."11"

What)are)the)requirements)for)ventures)and)funds?)

Page 13: SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™

Measuring&Impact&

Pg."12"

How)do)we)measure)impact?)

“A(standard(with(a(ra1ng(system(can(help(hold(the(line(on(social(impact(and(differen1ate(those(who(are(truly(making(a(difference(from(those(who(are(simply(telling(a(story."&Antony)BuggRLevine,)Author,)Impact)InvesTng)&)CEO,)Nonprofit)Finance)Fund)(NFF)"

Ra9ngs:&For[profit"organiza?ons"are"required"to"complete"either"a"Global"Impact"Inves?ng"Ra?ngs"and"aKain"a"score"of"100,or"be"a"B"Corp.&"Metrics:&Each"issuer"is"required"to"submit"5"key"metrics."&

Narra9ve:&All"issuers"must"have"an"impact"narra?ve,"which"explains"the"impact"they"are"hoping"to"achieve."&

Page 14: SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™

Third&Party&Ra9ngs&Providers&

""

GIIRS"offers"a"company"seeking"investment"capital"a"ra?ng"of"its"social"and"environmental"impact"including:"""

1.  an"overall"ra?ng;""2.  ra?ngs"in"approximately"15"sub[categories;""3.  key"performance"indicators"(KPI's)"relevant"to"the"company's"

industry,"geography,"size,"and"social"mission;"and"benchmark"data"highligh?ng"a"company's"performance"as"compared"to"its"peers."

Pg."13"

Global)Impact)InvesTng)RaTngs)System)

Page 15: SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™

Third&Party&Ra9ngs&Providers&

•  B Corp is a third-party certification for companies using the power of business to solve social or environmental problems.

•  Certified B Corps are committed to the idea of holistic success that takes into account community investment, environmental impact and workplace experience. They are committed to the “big idea” of using business as a force for good and they’re willing to have an outside group measure their effort & publish the results for all the world to see.

"Pg."14"

B)Corps)(Benefit)CorporaTons))

Page 16: SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™

Becoming&a&B&Corps&

1.  Take"the"B"Impact"Assessment"  1"–"3"hours"of"ini?al"self"assessment"  Be"prepared"by"having"all"your"financials"and"business"sta?s?cs"available"to"speed"the"

process"  At"the"end"of"the"assessment"you"will"be"provided"a"B"Impact"ra?ng"

2.  Complete"an"Assessment"Review"  A"B"Labs"staff"member"will"call"and"go"through"the"ques?onnaire"with"you"and"provide"

you"an"assessment"of"what"your"ra?ng"truly"is."

3.  Submit"Suppor?ng"Documenta?on"  The"Assessment"will"randomly"select"8"–"12"ques?ons"answered"in"the"affirma?ve"and"

will"ask"for"further"details"that"demonstrate"those"prac?ces."

4.  Complete"Disclosure"Ques?onnaire"  Your"company"must"disclose"any"sensi?ve"prac?ces,"fines"and"sanc?ons"related"to"the"

company"or"its"partners."

Pg."15"

Page 17: SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™

Pg."16"

Investor"Search"Screen"

Page 18: SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™

Pg."17"

Page 19: SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™

Pg."18"

Page 20: SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™

Team&

Pg."19"

Adam&Spence&Founder)&)UDP)Social"entrepreneur"with"10+"years"senior"leadership"experience."

Carlos&Pinto&Lobo&Chief)Compliance)Officer)25+"years"senior"leadership"experience"in"compliance"in"mainstream"finance."

Tris9na&Sinopoli&Project)Coordinator)York"University"business"grad"with"experience"in"local"government.""

Who)is)behind)the)SVX?)

Page 21: SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™

Team&

Pg."20"

Legal&Counsel&

Background&Checks&

Third&Party&Impact&Assessment&

STRATEGIC&PARTNERS&

Who)is)behind)the)SVX?)

Board&of&Directors&

 Dr.&Ilse&Treurnicht,&CEO,"MaRS" Ted&Anderson,&Director,"MaRS"Centre"for"Impact"Inves?ng"

 Grace&Lee&Reynolds,&VP"Finance,"MaRS"&

Advisors&  Kevin&Doyle,"Director,"TMX"Group"Inc." Aaron&Emes,"Partner,"Torys"LLP"  Catherine&De&Gius9,&Associate,"Torys"LLP" Allyson&Hewi\,"Director,"MaRS" Marc&Marzo\o,"Associate,"Gryphon"Investment"Counsel"

 Don&McCreesh,"Former"Chair,"Imagine"Canada"  Robert&Peterman,"Director,"TMX"Group"Inc."  Cynthia&Peters,"Owner,"From"the"Farm"Enterprises" Nelson&Switzer,"Director,"PwC" Alberta&Leung,"Partner,"KPMG"

Pla]orm&Development&

Page 22: SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™

Pg."21"

Next&Steps&What)is)next)for)the)SVX)plaHorm?)

  Outreach&and&Pipeline&Building.&We"are"con?nuing"to"build"our"pipeline"of"ventures,"funds,"investors"and"service"providers."

  Public&Launch.&We"launched"the"SVX"at"the"TMX"on"September"19th,"and"since"then"12"ventures"have"placed"their"offering"on"the"SVX"with"more"in"the"background"

  Franchising.&We"are"pursuing"opportuni?es"to"franchise"the"plaporm"in"Canada,"US,"and"around"the"world,"and"exploring"leveraging"the"plaporm"for"other"formats,"including"crowdfunding."

Page 23: SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™

Resources&

SVX:&h\p://www.svx.ca&

MaRS&Discovery&District:&h\p://www.marsdd.com&

GIIRS:&h\p://giirs.org&

B&Corps:&h\p://www.bcorpora9on.net&

IRIS:&h\p://iris.thegiin.org&

SocialFinance.ca:&www.socialfinance.ca&

&

&

Pg."22"

Page 24: SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™

Thank&You&Carlos&Pinto&Lobo&

Chief"Compliance"Officer,"SVX"[email protected]"[email protected]""

Pg."23"